Published in Visc Med on November 30, 2016
Management strategies in resection for hilar cholangiocarcinoma. Ann Surg (1992) 3.69
Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol (2012) 3.56
Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg (2008) 3.16
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut (2012) 2.91
Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg (1990) 2.86
Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg (2000) 2.55
Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol (2006) 2.29
Diagnosis and treatment of cholangiocarcinoma. Oncologist (2004) 2.00
Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg (2001) 1.99
Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg (2013) 1.91
Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg (2003) 1.59
Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality. Langenbecks Arch Surg (2003) 1.48
Is Liver Transplantation Appropriate for Patients with Potentially Resectable De Novo Hilar Cholangiocarcinoma? J Am Coll Surg (2015) 1.40
Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients. Ann Surg (2012) 1.37
Pathology of cholangiocarcinoma. Abdom Imaging (2004) 1.23
The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. J Am Coll Surg (2012) 1.23
Magnetic resonance imaging of cholangiocarcinoma. Semin Liver Dis (2004) 1.20
Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med Mol Imaging (2002) 1.06
Indications for portal vein embolization in perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci (2014) 0.97
Hilar cholangiocarcinoma: expert consensus statement. HPB (Oxford) (2015) 0.96
Left hepatectomy or left trisectionectomy with resection of the caudate lobe and extrahepatic bile duct for hilar cholangiocarcinoma (with video). J Hepatobiliary Pancreat Sci (2012) 0.92
Patterns of initial disease recurrence after resection of biliary tract cancer. Oncology (2012) 0.91
Multimodality treatment of intrahepatic cholangiocarcinoma: A review. J Surg Oncol (2016) 0.88
Biliary ductal involvement of hilar cholangiocarcinoma: multidetector computed tomography versus magnetic resonance cholangiography. J Comput Assist Tomogr (2007) 0.87
Surgery for Recurrent Biliary Tract Cancer: A Single-center Experience With 74 Consecutive Resections. Ann Surg (2015) 0.86
Preoperative Sequential Portal and Hepatic Vein Embolization in Patients with Hepatobiliary Malignancy. World J Surg (2015) 0.86
Surgery Alone Versus Surgery Followed by Chemotherapy and Radiotherapy in Resected Extrahepatic Bile Duct Cancer: Treatment Outcome Analysis of 336 Patients. Cancer Res Treat (2015) 0.81
A Nomogram to Predict Hypertrophy of Liver Segments 2 and 3 After Right Portal Vein Embolization. J Gastrointest Surg (2016) 0.80
Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma. Cancer Chemother Pharmacol (2016) 0.79
Correct diagnosis of vascular encasement and longitudinal extension of hilar cholangiocarcinoma by four-channel multidetector-row computed tomography. Tohoku J Exp Med (2009) 0.78
Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer (2016) 0.78
Resectable Cholangiocarcinoma: Reviewing the Role of Adjuvant Strategies. Clin Med Insights Oncol (2016) 0.77
Sequential preoperative hepatic vein embolization after portal vein embolization for extended left hepatectomy in colorectal liver metastases. World J Surg Oncol (2013) 0.77
Neoadjuvant chemoradiation followed by orthotopic liver transplantation in cholangiocarcinomas: the emory experience. J Gastrointest Oncol (2016) 0.77
Defining the possible therapeutic benefit of lymphadenectomy among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma. J Surg Oncol (2016) 0.77
ALPPS for primary and secondary liver tumors. Int J Surg (2016) 0.77
Concomitant hepatic artery resection for advanced perihilar cholangiocarcinoma: a case-control study with propensity score matching. J Hepatobiliary Pancreat Sci (2016) 0.76
Safety and outcome of combined liver and pancreatic resections. Br J Surg (2014) 0.76
Surgical and Radiological Studies on the Length of the Hepatic Ducts. World J Surg (2015) 0.76
Cholangiocarcinoma. Visc Med (2016) 0.75